Market Tracker

04/28 5:16pm ET

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

5.40
Delayed Data
As of Apr 28
 -0.04 / -0.74%
Today’s Change
3.05
Today|||52-Week Range
10.90
+2.08%
Year-to-Date
No recent news for Cyclacel Pharmaceuticals Inc.

Today’s Trading

Previous close5.44
Today’s open5.40
Day’s range5.27 - 5.48
Volume26,060
Average volume (3 months)653,619
Market cap$23.1M
Dividend yield--
Data as of 3:59pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+35.19%
Earnings growth (this year)+35.71%
Earnings growth (next 5 years)--
Revenue growth (last year)-56.64%
P/E ratioNM
Price/Sales21.49
Price/Book1.61

Competitors

 Today’s
change
Today’s
% change
AVIRAviragen Therapeutic...-0.01-1.67%
CLRBCellectar Bioscience...+0.01+0.57%
ABIOARCA Biopharma Inc-0.05-1.85%
OGENOragenics Inc+0.03+7.50%
Data as of 4:02pm ET, 04/28/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$843.0K
Annual profit (last year)-$11.8M
Net profit margin-1,398.70%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Spiro Rombotis
COO, CFO, Secretary, Director &
Executive VP
Paul McBarron
Corporate headquarters
Berkeley Heights, New Jersey

Forecasts